Technical Analysis for ARCT - Arcturus Therapeutics Ltd.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 26.55 | 1.45% | 0.38 |
Earnings due: May 8
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Doji - Bullish? | Reversal | 1.45% | |
Stochastic Reached Oversold | Weakness | 1.45% | |
Wide Bands | Range Expansion | 1.45% | |
Gapped Down | Weakness | 1.45% | |
Oversold Stochastic | Weakness | 1.45% | |
Wide Bands | Range Expansion | -1.59% | |
Oversold Stochastic | Weakness | -1.59% |
Alert | Time |
---|---|
Possible NR7 | about 14 hours ago |
60 Minute Opening Range Breakout | about 15 hours ago |
Rose Above Previous Day's High | about 15 hours ago |
Up 2% | about 19 hours ago |
Up 1% | about 19 hours ago |
Get a Trading Assistant
- Earnings date: 05/08/2024
Arcturus Therapeutics Ltd. Description
Alcobra Ltd is a development-stage biopharmaceutical company. The Company is focused on development and commercialization of its lead product candidates, including MDX and ADAIR. MDX is a oral drug, for the treatment of ADHD and other cognitive disorders, including Fragile X. MDX is a combined rapid onset ER formulation of the chemical pyridoxine pyroglutamate, which is more commonly known as metadoxine. MDX consists of a single bi-layer oral tablet, which includes both a rapid onset release metadoxine formulation and a slow release metadoxine formulation together providing the desired dual release profile. The new extended-release formulation prolongs the human plasma levels of metadoxine for up to 12 hours, which results in enhanced efficacy benefits. ADAIR is an oral, semi-solid, liquid-filled, hard gelatin capsule of an abuse-deterrent IR formulation of dextroamphetamine sulfate, which is manufactured as 10 mg capsules.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Health Sciences Drugs Pharmacology Euphoriants Amphetamine Cognitive Disorders Glutamate Tablet Adhd Taar1 Agonists
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 43.81 |
52 Week Low | 17.5238 |
Average Volume | 500,852 |
200-Day Moving Average | 29.92 |
50-Day Moving Average | 33.82 |
20-Day Moving Average | 29.60 |
10-Day Moving Average | 27.41 |
Average True Range | 1.85 |
RSI (14) | 36.31 |
ADX | 34.79 |
+DI | 12.82 |
-DI | 29.71 |
Chandelier Exit (Long, 3 ATRs) | 28.43 |
Chandelier Exit (Short, 3 ATRs) | 30.97 |
Upper Bollinger Bands | 34.52 |
Lower Bollinger Band | 24.68 |
Percent B (%b) | 0.19 |
BandWidth | 33.24 |
MACD Line | -2.08 |
MACD Signal Line | -1.91 |
MACD Histogram | -0.1687 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 28.08 | ||||
Resistance 3 (R3) | 28.01 | 27.44 | 27.83 | ||
Resistance 2 (R2) | 27.44 | 27.05 | 27.47 | 27.74 | |
Resistance 1 (R1) | 26.99 | 26.81 | 27.22 | 27.06 | 27.65 |
Pivot Point | 26.42 | 26.42 | 26.53 | 26.45 | 26.42 |
Support 1 (S1) | 25.97 | 26.03 | 26.20 | 26.04 | 25.45 |
Support 2 (S2) | 25.40 | 25.79 | 25.43 | 25.36 | |
Support 3 (S3) | 24.95 | 25.40 | 25.28 | ||
Support 4 (S4) | 25.02 |